AQR Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-980,971
| Closed | -$97.4M | – | 2252 |
|
|
2019
Q3 | $97.4M | Sell |
980,971
-54,567
| -5% | -$5.18M | 0.11% | 215 |
|
|
2019
Q2 | $95.7M | Buy |
1,035,538
+10,022
| +1% | +$952K | 0.11% | 226 |
|
|
2019
Q1 | $96.7M | Sell |
1,025,516
-5,661,663
| -85% | -$495M | 0.1% | 233 |
|
|
2018
Q4 | $429M | Buy |
6,687,179
+2,596,834
| +63% | +$192M | 0.5% | 49 |
|
|
2018
Q3 | $366M | Buy |
4,090,345
+1,143,027
| +39% | +$101M | 0.35% | 67 |
|
|
2018
Q2 | $234M | Sell |
2,947,318
-3,152,880
| -52% | -$262M | 0.24% | 113 |
|
|
2018
Q1 | $545M | Buy |
6,100,198
+1,721,662
| +39% | +$165M | 0.59% | 31 |
|
|
2017
Q4 | $457M | Buy |
4,378,536
+2,378,345
| +119% | +$268M | 0.48% | 42 |
|
|
2017
Q3 | $292M | Buy |
2,000,191
+1,142,163
| +133% | +$156M | 0.35% | 72 |
|
|
2017
Q2 | $111M | Sell |
858,028
-53,516
| -6% | -$6.56M | 0.15% | 184 |
|
|
2017
Q1 | $113M | Buy |
911,544
+333,820
| +58% | +$39.9M | 0.15% | 188 |
|
|
2016
Q4 | $66.9M | Buy |
577,724
+90,646
| +19% | +$10.1M | 0.09% | 299 |
|
|
2016
Q3 | $50.9M | Buy |
487,078
+321,792
| +195% | +$34.8M | 0.08% | 343 |
|
|
2016
Q2 | $16.3M | Buy |
165,286
+66,978
| +68% | +$6.93M | 0.03% | 596 |
|
|
2016
Q1 | $9.84M | Sell |
98,308
-668,830
| -87% | -$68.9M | 0.02% | 691 |
|
|
2015
Q4 | $91.9M | Sell |
767,138
-769,476
| -50% | -$89M | 0.16% | 171 |
|
|
2015
Q3 | $166M | Buy |
1,536,614
+12,915
| +0.8% | +$1.6M | 0.33% | 70 |
|
|
2015
Q2 | $176M | Buy |
1,523,699
+259,377
| +21% | +$29.7M | 0.35% | 61 |
|
|
2015
Q1 | $146M | Buy |
1,264,322
+88,569
| +8% | +$10.6M | 0.33% | 76 |
|
|
2014
Q4 | $132M | Buy |
1,175,753
+65,424
| +6% | +$6.9M | 0.28% | 98 |
|
|
2014
Q3 | $105M | Sell |
1,110,329
-1,179,489
| -52% | -$106M | 0.29% | 80 |
|
|
2014
Q2 | $197M | Sell |
2,289,818
-274,000
| -11% | -$20.8M | 0.53% | 24 |
|
|
2014
Q1 | $179M | Sell |
2,563,818
-185,400
| -7% | -$14.7M | 0.54% | 28 |
|
|
2013
Q4 | $232M | Buy |
2,749,218
+442,244
| +19% | +$35M | 0.69% | 11 |
|
|
2013
Q3 | $178M | Buy |
2,306,974
+351,212
| +18% | +$24.6M | 0.63% | 14 |
|
|
2013
Q2 | $114M | Buy |
+1,955,762
| New | +$118M | 0.41% | 44 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
AQR Capital Management's CELG Position: Q4 2019 in Review
AQR Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 980,971 shares — an estimated $97.4M sold.
AQR Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $545M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- AQR Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- AQR Capital Management sold 980,971 Celgene Corp shares in Q4 2019, an estimated $97.4M.
- AQR Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- AQR Capital Management's Celgene Corp position peaked at $545M in Q1 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.